OVERVIEW

CORE VALUE

OUR HISTORY

  • Sep, 2025

    Launch of EASYPANG(Bowel Preparation Agent)

  • Apr, 2025

    [Generic Anti-Obesity Drug] Launch of Topimed XR (Extended-Release Tablet) Topiramate

  • Nov, 2024

    Selection of the Lead Organization for the Startup Growth Technology Development Program (Didimdol R&D) by the Ministry of SMEs and Startups

  • Apr, 2024

    Opening of R&D Center (Suwon Gwanggyo)

  • Nov, 2023

    Ewha Womans University Patent Technology Transfer

  • Jun, 2023

    ELSA002 Securing bioequivalence

  • May, 2023

    Signed Industry-Academia Cooperation Agreement with Dankook University

  • Mar, 2023

    Obtained Venture Company Accreditation for research and development company "L-Bio Science" (March 8th)

  • Feb, 2023

    Signed Industry-Academia Cooperation Agreement with Soonchunhyang University

  • Jan, 2023

    Established the first domestic production line for sustained-release injections of Dutasteride

    Signed a cooperative agreement for the joint development and production of an anti-obesity drug

  • Nov, 2022

    Signed a mutual cooperation agreement for the development of an anti-obesity drug

  • Jun, 2022

    Obtained certification for an In-house Research Institute

  • Dec, 2021

    Signed a research service contract with IMD Pharm Co., Ltd.

  • Sep, 2021

    Signed a research service contract for new drug development with Intro Bio Pharma Co., Ltd.

  • Aug, 2021

    Established L-Bio Science Co., Ltd.

ORGANIZATION

대표이사

  • 연구기획팀

  • 연구소

  • 경영지원팀

  • 재무팀

  • 임상(고문)

INFORMATION

TEL. 041.544.2911